Latest Insider Transactions at Bristol Myers Squibb CO (BMY)
This section provides a real-time view of insider transactions for Bristol Myers Squibb CO (BMY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BRISTOL MYERS SQUIBB CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BRISTOL MYERS SQUIBB CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 30
2021
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
25,000
-17.9%
|
$1,700,000
$68.06 P/Share
|
|
Jul 30
2021
|
Rupert Vessey EVP & President, Research |
SELL
Open market or private sale
|
Direct |
158,393
-53.79%
|
$10,770,724
$68.05 P/Share
|
|
Jul 30
2021
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
150,967
+8.96%
|
$8,605,119
$57.02 P/Share
|
|
Jul 30
2021
|
Sandra Leung EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
29,390
-7.96%
|
$1,998,520
$68.04 P/Share
|
|
Jul 30
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Open market or private sale
|
Direct |
2,466
-15.18%
|
$165,222
$67.9 P/Share
|
|
Jul 01
2021
|
Karen Murphy Santiago SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
547
-3.64%
|
$36,102
$66.56 P/Share
|
|
Jul 01
2021
|
Karen Murphy Santiago SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,069
+6.63%
|
-
|
|
Jul 01
2021
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,786
-28.94%
|
$315,876
$66.56 P/Share
|
|
Jul 01
2021
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
9,356
+36.13%
|
-
|
|
Jun 13
2021
|
Julia A Haller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
902
+7.79%
|
-
|
|
Jun 13
2021
|
Michael W Bonney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
902
+6.73%
|
-
|
|
Jun 03
2021
|
Julia A Haller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,949
+23.19%
|
-
|
|
Jun 03
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
738
-7.22%
|
$47,232
$64.8 P/Share
|
|
Jun 03
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,154
+17.4%
|
-
|
|
Jun 03
2021
|
Michael W Bonney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,949
+20.27%
|
-
|
|
May 10
2021
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Open market or private sale
|
Direct |
15,000
-31.94%
|
$975,000
$65.25 P/Share
|
|
May 10
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Open market or private sale
|
Direct |
1,118
-12.17%
|
$72,670
$65.0 P/Share
|
|
May 08
2021
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
7,994
-12.81%
|
$511,616
$64.44 P/Share
|
|
May 08
2021
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
17,245
+21.66%
|
-
|
|
May 05
2021
|
Rupert Vessey EVP & President, Research |
SELL
Open market or private sale
|
Direct |
30,546
-40.36%
|
$1,954,944
$64.29 P/Share
|
|
May 05
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Open market or private sale
|
Direct |
3,119
-16.11%
|
$199,616
$64.21 P/Share
|
|
Apr 01
2021
|
Elizabeth Mily EVP, Strategy & BD |
SELL
Payment of exercise price or tax liability
|
Direct |
2,952
-30.69%
|
$183,024
$62.93 P/Share
|
|
Apr 01
2021
|
Elizabeth Mily EVP, Strategy & BD |
BUY
Exercise of conversion of derivative security
|
Direct |
6,346
+41.64%
|
-
|
|
Apr 01
2021
|
Elizabeth Mily EVP, Strategy & BD |
BUY
Other acquisition or disposition
|
Direct |
847
+15.81%
|
-
|
|
Mar 22
2021
|
Giovanni Caforio Executive Chair of the Board |
SELL
Open market or private sale
|
Direct |
25,000
-4.51%
|
$1,550,000
$62.2 P/Share
|
|
Mar 10
2021
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,017
-1.43%
|
$601,020
$60.93 P/Share
|
|
Mar 10
2021
|
Paul Von Autenried EVP, Chief Information Officer |
BUY
Other acquisition or disposition
|
Direct |
2,854
+0.49%
|
-
|
|
Mar 10
2021
|
Paul Von Autenried EVP, Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,302
+2.8%
|
-
|
|
Mar 10
2021
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Other acquisition or disposition
|
Direct |
167
-0.13%
|
-
|
|
Mar 10
2021
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
3,505
-4.43%
|
$210,300
$60.93 P/Share
|
|
Mar 10
2021
|
Rupert Vessey EVP & President, Research |
BUY
Other acquisition or disposition
|
Direct |
139
+0.18%
|
-
|
|
Mar 10
2021
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
7,423
+8.58%
|
-
|
|
Mar 10
2021
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Payment of exercise price or tax liability
|
Direct |
14,589
-6.66%
|
$875,340
$60.93 P/Share
|
|
Mar 10
2021
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
BUY
Other acquisition or disposition
|
Direct |
3,450
+1.77%
|
-
|
|
Mar 10
2021
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
BUY
Exercise of conversion of derivative security
|
Direct |
31,575
+12.55%
|
-
|
|
Mar 10
2021
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Other acquisition or disposition
|
Direct |
257
-0.81%
|
-
|
|
Mar 10
2021
|
Karen Murphy Santiago SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
2,662
-4.23%
|
$159,720
$60.93 P/Share
|
|
Mar 10
2021
|
Karen Murphy Santiago SVP & Controller |
BUY
Other acquisition or disposition
|
Direct |
1,045
+1.83%
|
-
|
|
Mar 10
2021
|
Karen Murphy Santiago SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
7,483
+10.6%
|
-
|
|
Mar 10
2021
|
Karen Murphy Santiago SVP & Controller |
SELL
Other acquisition or disposition
|
Direct |
60
-0.66%
|
-
|
|
Mar 10
2021
|
Ann Powell EVP, Chief Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
14,329
-4.16%
|
$859,740
$60.93 P/Share
|
|
Mar 10
2021
|
Ann Powell EVP, Chief Human Resources |
BUY
Other acquisition or disposition
|
Direct |
4,179
+1.38%
|
-
|
|
Mar 10
2021
|
Ann Powell EVP, Chief Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
29,835
+7.9%
|
-
|
|
Mar 10
2021
|
Ann Powell EVP, Chief Human Resources |
SELL
Other acquisition or disposition
|
Direct |
244
-0.43%
|
-
|
|
Mar 10
2021
|
Sandra Leung EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
31,200
-1.67%
|
$1,872,000
$60.93 P/Share
|
|
Mar 10
2021
|
Sandra Leung EVP, General Counsel |
BUY
Other acquisition or disposition
|
Direct |
5,554
+0.36%
|
-
|
|
Mar 10
2021
|
Sandra Leung EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
50,373
+2.6%
|
-
|
|
Mar 10
2021
|
Sandra Leung EVP, General Counsel |
SELL
Other acquisition or disposition
|
Direct |
413
-0.12%
|
-
|
|
Mar 10
2021
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,978
-21.59%
|
$118,680
$60.93 P/Share
|
|
Mar 10
2021
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Other acquisition or disposition
|
Direct |
78
+0.84%
|
-
|